ESC 365 - Reversal of FXa inhibitors.

ESC Premium Access

Reversal of FXa inhibitors.

Session: Reversal of NOACs' effect: when and how?

Topic: Drug therapy

Speaker: Associate Professor S. Wassmann (Munich, DE)

Event: ESC Congress 2016

Congress Presentation

About the speaker

Associate Professor Sven Wassmann

Cardiology Pasing, Munich (Germany)

5 presentations

2 followers

3 more presentations in this session

When should I use reversal agents for NOACs?

Speaker: Professor G. Lip (Liverpool, GB)

Reversal of the thrombin inhibitor dabigatran.

Speaker: Professor A. Niessner (Vienna, AT)

Will the availability of specific reversal agents change the use of NOACs?

Speaker: Professor F. Verheugt (Amsterdam, NL)

Access the full session

Reversal of NOACs' effect: when and how?

Speakers: Associate Professor S. Wassmann, Professor G. Lip, Professor A. Niessner, Professor F. Verheugt

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by